Compare FICO & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FICO | VTR |
|---|---|---|
| Founded | 1956 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Real Estate Investment Trusts |
| Sector | Consumer Discretionary | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.2B | 35.2B |
| IPO Year | 1987 | 1998 |
| Metric | FICO | VTR |
|---|---|---|
| Price | $1,775.73 | $81.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $2,050.69 | $77.92 |
| AVG Volume (30 Days) | 194.1K | ★ 3.0M |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | ★ 29.78 | N/A |
| EPS | ★ 26.54 | 0.53 |
| Revenue | $1,990,869,000.00 | ★ $5,544,046,000.00 |
| Revenue This Year | $20.80 | $16.61 |
| Revenue Next Year | $16.38 | $9.31 |
| P/E Ratio | ★ $66.40 | $151.65 |
| Revenue Growth | 15.91 | ★ 16.38 |
| 52 Week Low | $1,300.00 | $56.68 |
| 52 Week High | $2,400.00 | $80.99 |
| Indicator | FICO | VTR |
|---|---|---|
| Relative Strength Index (RSI) | 55.64 | 73.66 |
| Support Level | $1,756.00 | $79.24 |
| Resistance Level | $1,800.69 | $80.88 |
| Average True Range (ATR) | 50.86 | 1.00 |
| MACD | -3.17 | -0.13 |
| Stochastic Oscillator | 58.74 | 96.98 |
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.